Cabot (NYSE:CBT) Reaches New 12-Month Low - Should You Sell?

Shares of Cabot Co. (NYSE:CBT - Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $73.63 and last traded at $74.69, with a volume of 715109 shares changing hands. The stock had previously closed at $76.41.

Analyst Ratings Changes

CBT has been the subject of a number of recent research reports. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. dropped their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. UBS Group decreased their price objective on Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research report on Monday, April 7th. Finally, StockNews.com lowered Cabot from a "buy" rating to a "hold" rating in a report on Wednesday, April 9th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $93.25.

Cabot Price Performance

The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The stock has a fifty day simple moving average of $83.53 and a two-hundred day simple moving average of $95.81. The company has a market cap of $4.29 billion, a PE ratio of 10.50, a price-to-earnings-growth ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, equities analysts predict that Cabot Co. will post 7.57 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Norges Bank purchased a new stake in shares of Cabot during the 4th quarter worth approximately $37,961,000. Millennium Management LLC grew its holdings in Cabot by 67.7% in the fourth quarter. Millennium Management LLC now owns 349,369 shares of the specialty chemicals company's stock valued at $31,901,000 after purchasing an additional 141,050 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Cabot by 10,385.0% in the first quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company's stock valued at $11,751,000 after buying an additional 139,990 shares in the last quarter. Copeland Capital Management LLC grew its stake in Cabot by 21.6% in the 4th quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company's stock valued at $69,521,000 after acquiring an additional 135,119 shares during the last quarter. Finally, American Century Companies Inc. raised its position in Cabot by 8.5% during the fourth quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company's stock worth $120,835,000 after acquiring an additional 103,380 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.